Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease

Journal of the Neurological Sciences

Volumn 323, Issue 1-2, 2012, Pages 25-32

  Leszek, Jerzy ^a   Sochocka, Marta ^b   Ga̧siorowski, Kazimierz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Brain hypoperfusion; Cerebral ischemia; Epigenetic modifications; Free radicals; Oxidative stress; Vascular factors

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANGIOTENSIN 1B RECEPTOR; APOLIPOPROTEIN E4; CORTICOSTERONE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DEXAMETHASONE; INDUCIBLE NITRIC OXIDE SYNTHASE; MYOCARDIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; PROOPIOMELANOCORTIN; REACTIVE OXYGEN METABOLITE; RIBOSOME DNA; SERUM RESPONSE FACTOR;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOTINYLATION; BLOOD PRESSURE; BLOOD VESSEL PERMEABILITY; BRAIN CIRCULUS ARTERIOSUS; BRAIN ISCHEMIA; BRAIN PERFUSION; CARDIOVASCULAR RISK; CELL DAMAGE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CPG ISLAND; DISEASE COURSE; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL IMPACT; ENZYME INDUCTION; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GLIA; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; HYPERTENSION; HYPOXIA; IN VITRO STUDY; LEUKOCYTE ADHERENCE; NERVE CELL; NERVE CELL CULTURE; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CARBONYLATION; PROTEIN GLYCOSYLATION; SMOOTH MUSCLE FIBER; VASCULAR AMYLOIDOSIS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 84867842594     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.09.010     Document Type: Review

References (136)

1. J. Hardy A hundred years of Alzheimer's disease research Neuron 52 2006 3 13
2. R. Cacabelos Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety, and depression Methods Find Exp Clin Pharmacol 29 Suppl. A 2007 1 91
3. S.E. Starkstein, L. Sabe, S. Vazquez, G.D.i. Lorenzo, A. Martinez, and G. Petracca Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease J Neurol Neurosurg Psychiatry 63 1997 66 73
4. T. Dziedzic Systemic inflammatory markers and risk of dementia Am J Alzheimers Dis Other Demen 21 2006 258 262
5. R. Cacabelos Pharmacogenomic protocols in CNS disorders and dementia Neurodegener Dis 7 2010 167 169
6. W. Kalback, C. Esh, E.M. Castano, A. Rahman, T. Kokjohn, and D.C. Luehrs Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease Neurol Res 26 2004 525 539
7. I.F. Smith, K.N. Green, and F.M. LaFeria Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals Cell Calcium 38 2005 427 437
8. P.H. Reddy, and M.F. Beal Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 49 2005 618 632
9. P.H. Reddy Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons Antioxid Redox Signal 9 2007 1647 1658
10. Z. Nagy The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease Biochim Biophys Acta 1772 2007 402 408
11. X. Zhu, M.A. Smith, K. Honda, G. Aliev, P.I. Moreira, and A. Nunomura Vascular oxidative stress in Alzheimer disease J Neurol Sci 257 2007 240 246
12. M.A. Lopes, M.J. Firbank, M. Widdrington, A.M. Blamire, R.N. Kalaria, and J.T. O'Brien Post-stroke dementia: the contribution of thalamus and basal ganglia changes Int Psychogeriatr 12 2011 1 9
13. R. Kalaria Similarities between Alzheimer's disease and vascular dementia J Neurol Sci 203-204 2002 29 34
14. T.B. Cumming, and A. Brodtmann Can stroke cause neurodegenerative dementia? Int J Stroke 6 2011 416 424
15. H. Engelberg Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial Dement Geriatr Cogn Disord 18 2004 278 298
16. X. Sun, G. He, H. Qing, W. Zhou, F. Dobie, and F. Cai Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression Proc Natl Acad Sci U S A 103 2006 18727 18732
17. J.B. Pinkston, N. Aleksseva, and E. Gonzales Storke and dementia Neurol Res 31 2009 824 831
18. L.S. Honig, M.X. Tang, S. Albert, R. Costa, J. Luchsinger, and J. Manly Stroke and the risk of Alzheimer disease Arch Neurol 60 2003 1707 1712
19. W. Dai, O.L. Lopez, O.T. Carmichael, J. Becker, L.H. Kuller, and M. Gach Abnormal regional cerebral blood flow in cognitively normal elderly subjects with hypertension Stroke 39 2008 349 354
20. B.R. Reed, D.M. Mungas, J.H. Kramer, W. Ellis, H.V. Vinters, and C. Zarow Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease Brain 130 2007 731 739
21. N.D. Prins, E.J. van Dijk, T. den Heijer, S.E. Vermeer, J. Jolles, and P.J. Koudstaal Cerebral small-vessel disease and decline in information processing speed, executive function and memory Brain 128 2007 2034 2041
22. J.C. de la Torre How do heart disease and stroke become risk factors for Alzheimer's disease? Neurol Res 28 2006 637 644
23. T. den Heijer, L.J. Launer, N.D. Prins, E.J. van Dijk, S.E. Vermeer, and A. Hofman Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe Neurology 64 2005 263 267
24. P.B. Gorelick Risk factors for vascular dementia and Alzheimer disease Stroke 25 11 Suppl. 1 2004 2620 2622
25. M. Koistinaho, and J. Koistinaho Interactions between Alzheimer's disease and cerebral ischemia-focus on inflammation Brain Res Brain Res Rev 48 2005 240 250
26. J.P. Qi, H. Wu, Y. Yang, D.D. Wang, Y.X. Chen, and Y.H. Gu Cerebral ischemia and Alzheimer's disease: the expression of amyloid-beta and apolipoprotein E in human hippocampus J Alzheimers Dis 12 2007 335 341
27. R.N. Kalaria Vascular factors in Alzheimer's disease Int Psychogeriatr 15 Suppl. 1 2003 47 52
28. A.H. Vagnucci Jr., and W.W. Li Alzheimer's disease and angiogenesis Lancet 361 2003 605 608
29. D.R. Thal, E. Ghebremedhin, M. Orantes, and O.D. Wiestler Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline J Neuropathol Exp Neurol 62 2003 1287 1301
30. J.C. de la Torre Vascular basis of Alzheimer's pathogenesis Ann N Y Acad Sci 977 2002 196 215
31. W.M. van der Flier, E.C. van Straaten, F. Barkhof, A. Verdelho, S. Madureira, and L. Pantoni Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study Stroke 36 2005 2116 2120
32. G.C. Román, and R.N. Kalaria Vascular determinants of cholinerigic deficits in Alzheimer disease and vascular dementia Neurobiol Aging 27 2006 1769 1785
33. R. Deane, and B.V. Zlokovic Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease Curr Alzheimer Res 4 2007 191 197
34. J.J. Kril, S. Patel, A.J. Harding, and G.M. Halliday Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss J Neurol Neurosurg Psychiatry 72 2002 747 751
35. H. Kitaguchi, M. Ihara, H. Saiki, R. Takahashi, and H. Tomimoto Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease Neurosci Lett 417 2007 128 131
36. H.S. Markus Genes endothelial function and cerebral small vessel disease in man Exp Physiol 93 2008 121 127
37. D.Y. Lee, I.L. Choo, K.W. Kim, J.H. Jhoo, J.C. Youn, and U.Y. Lee White matter changes associated with psychotic symptoms in Alzheimer's disease patients J Neuropsychiatry Clin Neurosci 18 2006 191 198
38. B.D. Zipser, C.E. Johanson, L. Gonzalez, T.M. Berzin, R. Tavares, and C.M. Hulette Microvascular injury and blood-brain barrier leakage in Alzheimer's disease Neurobiol Aging 28 2007 977 986
39. J.C. de la Torre Cerebrovascular gene linked to Alzheimer's disease pathology Trends Mol Med 11 2005 534 536
40. C. Iadecola, and P.B. Gorelick Converging pathogenic mechanisms in vascular and neurodegenerative dementia Stroke 34 2003 335 337
41. J.A. Schneider, R.S. Wilson, J.L. Bienias, D.A. Evans, and D.A. Bennett Cerebral infarctions and the likelihood dementia from Alzheimer disease pathology Neurology 62 2004 1148 1155
42. L. Rojo, M.K. Sjöberg, P. Hernández, C. Zambrano, and R.B. Maccioni Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease J Biomed Biotechnol 3 2006 73976
43. C. Qiu, B. Winblad, and L. Fratiglioni The age-dependent relation of blood pressure to cognitive function and dementia Lancet Neurol 4 2005 487 499
44. A.E. Roher, C. Esh, A. Rahman, T.A. Kokjohn, and T.G. Beach Atherosclerosis of cerebral arteries in Alzheimer's disease Stroke 35 11 Suppl. 1 2004 2623 2627
45. B.V. Zlokovic Neurovascular mechanisms of Alzheimer's neurodegeneration Trends Neurosci 28 2005 202 208
46. T. Miyakawa Vascular pathology in Alzheimer's disease Ann N Y Acad Sci 977 2002 303 305
47. M. Sadowski, J. Pankiewicz, H. Scholtzova, Y.S. Li, D. Quartermain, and K. Duff Links between the pathology of Alzheimer's disease and vascular dementia Neurochem Res 29 2004 1257 1266
48. J.A. Luchsinger, C. Reitz, L.S. Honig, M.X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology 65 2005 545 551
49. T. Vogel, R. Verreault, G. Kaltenbach, and M. Berther Hypertension and Alzheimer's disease Presse Med 34 2005 809 812
50. I. Skoog, and D. Gustafson Hypertension and related factors in the etiology of Alzheimer's disease Ann N Y Acad Sci 977 2002 29 36
51. C. Rosendorff, M.S. Beeri, and J.M. Silverman Cardiovascular risk factors for Alzheimer's disease Am J Geriatr Cardiol 16 2007 143 149
52. S. Gharibzadeh, S.S. Hoseini, and S. Mahdavi Acute hypertensive crisis may be a risk factor for Alzheimer's disease induction and progression J Neuropsychiatry Clin Neurosci 19 2007 483 484
53. J. Schrader The significance of arterial hypertension for the development of dementia MMW Fortschr Med 146 2004 40 42
54. D.S. Dede, B. Yavuz, B.B. Yavuz, M. Cankurtaran, M. Halil, and Z. Ulger Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease? J Am Geriatr Soc 55 2007 1613 1617
55. M.M. Mielke, P.B. Rosenberg, J. Tschanz, L. Cook, C. Corcoran, and K.M. Hayden Vascular factors predict rate of progression in Alzheimer disease Neurology 69 2007 1850 1858
56. O.C. Suter, T. Sunthorn, R. Kraftsik, J. Straubel, P. Darekar, and K. Khalilii Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer's disease Stroke 33 2002 1986 1992
57. M.V. Vernooij, A. van der Lugt, M.A. Ikram, P.A. Wielopolski, H.A. Vrooman, and A. Hofman Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study J Cereb Blood Flow Metab 28 2008 412 419
58. B.V. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders Nat Rev Neurosci 12 2011 723 738
59. R.D. Bell, E.A. Winkler, A.P. Sagare, I. Singh, B. LaRue, and R. Deane Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging Neuron 68 2010 409 427
60. N. Chow, R.D. Bell, R. Deane, J.W. Streb, J. Chen, and A. Brooks Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype PNAS 104 2007 823 828
61. R.D. Bell, R. Deane, N. Chow, X. Long, A. Sagare, and I. Singh SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells Nat Cell Biol 11 2009 143 153
62. Z. Wu, H. Guo, N. Chow, J. Sallstrom, R.D. Bell, and R. Deane Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease Nat Med 11 2005 959 965
63. A. Sagare, R. Deane, R.D. Bell, B. Johnson, K. Hamm, and R. Pendu Clearance of amyloid-β by circulating lipoprotein receptors Nat Med 13 2007 1029 1031
64. R. Deane, Z. Wu, A. Sagare, J. Davis, S. Du Yan, and K. Hamm LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms Neuron 43 2004 333 344
65. O.R. Monro, J.B. Mackic, S. Yamada, M.B. Segal, J. Ghiso, and C. Maurer Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood Neurobiol Aging 23 2002 405 412
66. G.E. Mann, B.V. Zlokovic, and Yuclilevich Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon Biochim Biophys Acta 819 1985 241 248
67. B.V. Zlokovic, and M.L. Appuzzo Cellular and molecular neurosurgery: pathways from concept to reality-part I: target disorders and concept approaches to gene therapy of the central nervous system Neurosurgery 40 1997 789 803 [discussion 803-804]
68. E. Hamel, N. Nicolakakis, T. Aboulkassim, B. Ongali, and X.K. Tong Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease Exp Physiol 93 2008 116 120
69. G. Aliev, M.A. Smith, M.E. Obrenovich, J.C. de la Torre, and G. Perry Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease Neurotox Res 5 2003 491 504
70. G. Aliev, M.E. Obrenovich, M.A. Smith, and G. Perry Hypoperfusion, mitochondria failure, oxidative stress and Alzheimer disease J Biomed Biotechnol 3 2003 162 163
71. E. Farkas, M.C. de Wilde, A.J. Kiliaan, and P.G. Luiten Chronic cerebral hypoperfusion-related neuropathologic changes and compromised cognitive status: window of treatment Drugs Today (Barc) 38 2002 365 376
72. D. Zádori, Z. Datki, and B. Penke The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease-facts and hypotheses Ideggyogy Sz 60 2007 428 437
73. D.G. Munoz Leukoaraiosis and ischemia: beyond the myth Stroke 37 2006 1348 1349
74. J.C. de la Torre Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion? Ann Neurol 57 2005 783 784
75. K. Kogure, and H. Kato Altered gene expression in cerebral ischemia Stroke 24 1993 2121 2127
76. M.S. Beeri, M. Rapp, J.M. Silverman, J. Schmeidler, H.T. Grossman, and J.T. Fallon Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers Neurology 66 2006 1399 1404
77. C. Bergmann, and M. Sano Cardiac risk factors and potential treatments in Alzheimer's disease Neurol Res 28 2006 595 604
78. S.M. de la Monte, and J.R. Wands Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease J Alzheimers Dis 9 2006 167 181
79. G. Aliev, M.A. Smith, J.C. de la Torre, and G. Perry Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease Mitochondrion 4 2004 649 663
80. X. Zhang, K. Zhou, R. Wang, J. Cui, S.A. Lipton, and F.F. Liao Hypoxia-inducible factor 1 alpha(HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation J Biol Chem 15 2007 10873 10880
81. W.S. Liang, E.M. Reiman, J. Valla, T. Dunckley, T.G. Beach, and A. Grover Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons Proc Natl Acad Sci U S A 105 2008 4441 4446
82. K.G. Manton, S. Volovik, and A. Kulminski ROS effects on neurodegeneration in Alzheimer's disease and related disorders: on environmental stresses of ionizing radiation Curr Alzheimer Res 1 2004 277 293
83. A. Nunomura, R.J. Castellani, X. Zhu, P.I. Moreira, G. Perry, and M.A. Smith Involvement of oxidative stress in Alzheimer disease J Neuripathol Exp Neurol 65 2006 631 641
84. K. Sas, H. Robotka, J. Toldi, and L. Vécsei Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders J Neurol Sci 257 2007 221 239
85. J. Leszek, M. Ferens-Sieczkowska, and I. Ka̧tnik-Prastowska Fluorescent advanced glycation endproducts in sera of Alzheimer's disease patients Perspect Neurosci 2005 373 381
86. J. Leszek, K. Małyszczak, A. Bartyś, M. Staniszewska, and A. Gamian Analysis of serum of patients with Alzheimer's disease for the level of advanced glycation end products Am J Alzheimers Dis Other Demen 21 2006 360 365
87. J. Wang, L. Ho, L. Chen, Z. Zhao, W. Zhao, and X. Qian Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse Alzheimer disease J Clin Invest 117 2007 3393 3402
88. [Wednesday, May 15,4:00 pm-6:00 pm] P.B. Gorelick Spotlighting hypertension and the brain: does controlling blood pressure reduce the risk of recurrent stroke and dementia? What we know about hypertension and dementia: mechanisms and interventions Am J Hypertens 15 2002 237A
89. I. Skoog, and D. Gustafson Update on hypertension and Alzheimer's disease Neurol Res 28 2006 605 611
90. C. Humpel, and J. Marksteiner Cerebrovascular damage as a cause for Alzheimer's disease Curr Neurovasc Res 2 2005 341 347
91. C. Wu, D. Zhou, C. Wen, L. Zhang, P. Como, and Y. Qiao Relationship between blood pressure and Alzheimer's disease in Linxian country, China Life Sci 10 2003 1125 1133
92. A.S. Khachaturian, P.P. Zandi, C.G. Lyketsos, K.M. Hayden, I. Skoog, and M.C. Norton Antihypertensive medication use and incident Alzheimer disease: the Cache County Study Arch Neurol 63 2006 686 692
93. H. Matsuda, N. Araki, I. Kuji, T. Ohkubo, E. Imabayashi, and K. Shimazu Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease Clin Nucl Med 33 2008 34 35
94. P.M. Doraiswamy, and G.L. Xiong Pharmacological strategies for the prevention of Alzheimer's disease Expert Opin Pharmacother 7 2006 1 10
95. J. Mill Toward an integrated genetic and epigenetic approach to Alzheimer's disease Neurobiol Aging 32 2011 1188 1191
96. J.P. Hamilton Epigenetics: principles and practice Dig Dis 29 2011 130 135
97. J.J. Day, and J.D. Sweatt Epigenetic mechanisms in cognition Neuron 70 2011 813 829
98. S. Patel, R.J. Shah, P. Coleman, and M. Sabbagh Potential peripheral biomarkers for the diagnosis of Alzheimer's disease Int J Alzheimers Dis 2011 2011 572495
99. P. Narayan, and M. Dragunow Pharmacology of epigenetics in brain disorders Br J Pharmacol 159 2010 285 303
100. M.R. Penner, T.L. Roth, C.A. Barnes, and J.D. Sweatt An epigenetic hypothesis of aging-related cognitive dysfunction Front Aging Neurosci 2 2010 9
101. B.M. Gruber Epigenetics and etiology of neurodegenerative diseases Postepy Hig Med Dosw 65 2011 542 551
102. D. Mastroeni, A. McKee, A. Grover, J. Rogers, and P.D. Coleman Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease PLoS One 4 2009 e6617
103. S.C. Wang, B. Oelze, and A. Schumacher Age specific epigenetic drift in late-onset Alzheimer's disease PLoS One 3 2008 e2698
104. L. Chouliaras, B.P. Rutten, G. Kenis, O. Peerbooms, P.J. Visser, and F. Verhey Epigenetic regulation in the pathophysiology of Alzheimer's disease Prog Neurobiol 90 2010 498 510
105. M. Pietrzak, G. Rempala, P.T. Nelson, J.J. Zheng, and M. Hetman Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease PLoS One 6 2011 e22585
106. Q. Ding, W.R. Markesbery, Q. Chen, F. Li, and J.N. Keller Ribosome dysfunction is an early event in Alzheimer's disease J Neurosci 25 2005 9171 9175
107. P.T. Nelson, and J.N. Keller RNA in brain disease: no longer just the messenger in the middle J Neuropathol Exp Neurol 66 2007 461 468
108. J. Gräff, and I.M. Mansuy Epigenetic codes in cognition and behaviour Behav Brain Res 192 2008 70 87
109. A.R. Cyr, and F.E. Domann The redox basis of epigenetic modifications: from mechanisms to functional consequences Antioxid Redox Signal 15 2011 551 589
110. N.H. Zawia, D.K. Lahiri, and F. Cardozo-Pelaez Epigenetics, oxidative stress, and Alzheimer disease Free Radic Biol Med 46 2009 1241 1249
111. Y. Jiang, B. Langley, F.D. Lubin, W. Renthal, M.A. Wood, and D.H. Yasui Epigenetics in the nervous system J Neurosci 28 2008 11753 11759
112. R. Balazs, J. Vernon, and J. Hardy Epigenetic mechanisms in Alzheimer's disease: progress but much to do Neurobiol Aging 32 2011 1181 1187
113. I. Szumiel, and N. Foray Chromatin acetylation, β-amyloid precursor protein and its binding partner FE65 in DNA double strand break repair Acta Biochim Pol 58 2011 11 18
114. D.M. Chuang, Y. Leng, Z. Marinova, H.J. Kim, and C.T. Chiu Multiple roles of HDAC inhibition in neurodegenerative conditions Trends Neurosci 32 2009 591 601
115. R.M. Stilling, and A. Fischer The role of histone acetylation in age-associated memory impairment and Alzheimer's disease Neurobiol Learn Mem 96 2011 19 26
116. T.Y. Wu, C.P. Chen, and T.R. Jinn Alzheimer's disease: aging, insomnia and epigenetics Taiwan J Obstet Gynecol 49 2010 468 472
117. I.A. Qureshi, and M.F. Mehler Emerging themes in epigenetics: implications for understanding and treating nervous system disorders Epigenomics 2 2010 345 349
118. S.S. Hebert, J. Horre, and L. Nicolai Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression PNAS 105 2008 6415 6420
119. S. Bicker, and G. Schratt MicroRNAs: tiny regulators of synapse function in development and disease J Cell Mol Med 12 2008 1466 1476
120. W.X. Wang, B.W. Rajeev, A.J. Stromberg, N. Ren, G. Tang, and Q. Huang The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1 J Neurosci 28 2008 1213 1223
121. O.C. Maes, H.M. Chertkow, E. Wang, and H.M. Schipper MicroRNA: implications for Alzheimer disease and other human CNS disorders Curr Genomics 10 2009 154 168
122. D.C. Carrettiero, I. Hernendez, P. Neveu, T. Papagiannakopoulos, and K.S. Kosik The cochaperone BAG2 sweeps paired helical filament-insoluble tau from microtubule J Neurosci 29 2009 2151 2161
123. W.J. Lukiw Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus Neuroreport 18 2007 297 300
124. J.P. Cogswell, J. Ward, I.A. Taylor, M. Waters, Y. Shi, and B. Cannon Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways J Alzheimers Dis 14 2008 27 41
125. S.S. Hébert, K. Horré, L. Nicola, B. Bergmans, A.S. Papadopoulou, and A. Delacourte MicroRNA regulation of Alzheimer's amyloid precursor protein expression Neurobiol Dis 33 2009 422 428
126. N. Schonrock, Y.D. Ke, D. Humphreys, M. Staufenbiel, L.M. Ittner, and T. Preiss Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-β PLoS One 5 2010 e11070
127. D.K. Lahiri, N.H. Zawia, N.H. Greig, K. Sambamurti, and B. Maloney Early-life events may trigger biochemical pathways for Alzheimer's disease: the LEARn model Biogerontology 9 2008 375 379
128. D.K. Lahiri, and B. Maloney The LEARn (latent early-life associated regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposed remedial steps Exp Gerontol 45 2010 291 296
129. T. Lu, Y. Pan, S.Y. Kao, C. Li, L. Kohane, and J. Chan Gene regulation and DNA damage in the ageing human brain Nature 429 2004 883 891
130. C.M. Bolin, R. Basha, D. Cox, N.H. Zawia, B. Maloney, and D.K. Lahiri Exposure to lead and the developmental origin of oxidative DNA damage in aging brain FASEB J 20 2006 788 790
131. O. Campuzano, M.M. Castillo-Ruiz, L. Acarin, B. Castellano, and B. Gonzales Increased levels of proinflammatory cytokines in the aged rat brain attenuate injury-induced cytokine response after excitotoxic damage J Neurosci Res 87 2009 2484 2497
132. A. Plagemann, T. Harder, M. Brunn, A. Harder, K. Roepke, and M. Wittrock-Staar Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome J Physiol 587 2009 4963 4976
133. I.C. Weaver, N. Cervoni, F.A. Champagne, A.C. D'Alessio, S. Sharma, and J.R. Secki Epigenetic programming by maternal behavior Nat Neurosci 7 2004 847 854
134. P.D. Gluckman, M.A. Hanson, T. Buklijas, F.M. Low, and A.S. Beedle Epigenetic mechanisms that underpin metabolic and cardiovascular diseases Nat Rev Endocrinol 5 2009 401 408
135. L.M. Villeneuve, M.A. Reddy, L.L. Lanting, M. Wang, L. Meng, and R. Natarajan Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes PNAS 105 2008 9047 9052
136. A. El-Osta, D. Brasacchio, D. Yao, A. Pocai, P.L. Jones, and R.G. Roeder Transient high glucose causes persistent epigenetic changes and altered genome expression during subsequent normoglycemia J Exp Med 205 2008 2409 2417